These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 11437409
1. Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour). Tejpar S, Li C, Yu C, Poon R, Denys H, Sciot R, Van Cutsem E, Cassiman JJ, Alman BA. Br J Cancer; 2001 Jul 06; 85(1):98-101. PubMed ID: 11437409 [Abstract] [Full Text] [Related]
2. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S, Bapat B. Oncogene; 2004 Oct 28; 23(50):8260-71. PubMed ID: 15377999 [Abstract] [Full Text] [Related]
3. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development. Schmidt M, Patterson M, Farrell E, Münsterberg A. Dev Dyn; 2004 Mar 28; 229(3):703-7. PubMed ID: 14991726 [Abstract] [Full Text] [Related]
7. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Poon R, Smits R, Li C, Jagmohan-Changur S, Kong M, Cheon S, Yu C, Fodde R, Alman BA. Oncogene; 2001 Jan 25; 20(4):451-60. PubMed ID: 11313976 [Abstract] [Full Text] [Related]
8. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC. Oncogene; 2003 Aug 28; 22(36):5602-13. PubMed ID: 12944908 [Abstract] [Full Text] [Related]
9. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc. Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M. Cancer Res; 2003 Feb 15; 63(4):801-6. PubMed ID: 12591729 [Abstract] [Full Text] [Related]
10. Tcf4 can specifically recognize beta-catenin using alternative conformations. Graham TA, Ferkey DM, Mao F, Kimelman D, Xu W. Nat Struct Biol; 2001 Dec 15; 8(12):1048-52. PubMed ID: 11713475 [Abstract] [Full Text] [Related]
12. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, Bousdras K, Diss TC, O'Donnell P, Flanagan AM. Am J Surg Pathol; 2007 Sep 15; 31(9):1299-309. PubMed ID: 17721184 [Abstract] [Full Text] [Related]
13. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Gustavson MD, Crawford HC, Fingleton B, Matrisian LM. Mol Carcinog; 2004 Nov 15; 41(3):125-39. PubMed ID: 15457508 [Abstract] [Full Text] [Related]
14. Galectin-3, a novel binding partner of beta-catenin. Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A, Raz A. Cancer Res; 2004 Sep 15; 64(18):6363-7. PubMed ID: 15374939 [Abstract] [Full Text] [Related]
15. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line. Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K, Sekido Y. Oncogene; 2004 Jan 29; 23(4):964-72. PubMed ID: 14661054 [Abstract] [Full Text] [Related]
16. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor. Chesire DR, Isaacs WB. Oncogene; 2002 Dec 05; 21(55):8453-69. PubMed ID: 12466965 [Abstract] [Full Text] [Related]
17. Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Hlubek F, Jung A, Kotzor N, Kirchner T, Brabletz T. Cancer Res; 2001 Nov 15; 61(22):8089-93. PubMed ID: 11719433 [Abstract] [Full Text] [Related]